Here Are Sintx Technologies (NASDAQ: SINT) Second Quarter 2024 Results
Main Results Obtained From Finance Management Authority
- Profit Made: US$859.OK (up 69% from 2Q 2023).
- Total loss: US$2.20m(loss decreased out by 11% from 2Q 2023).
- US$3.49 loss per share (increased from US$122 loss in 2Q 2023).
These figures appear in the chart above are for the tracking12-month (TTM) period
Sintx Technologies Revenues and Earnings Beat Expectations
Revenue goes beyond analyst estimates by 23%. As a result, earnings per share (EPS) also exceeded analyst estimates by an impressive 100%.
Looking ahead, we predict revenue will grow by 7.6% per year on average over the next 2 years, slightly below the 8.1% growth forecast for the US Medical Equipment industry.
Reference: Website
Performance of the American Medical Equipment industry.
The company’s shares were up about 11% from a week ago.
Risk Analysis
Before you move towards the article First of all you should know about the 6 warning signs for Sintx Technologies (4 shouldn’t be ignored!) that we have written about.
Provide us feedback on this article. Concerned about the content? In case of any query contact us directly. Alternatively, email Informativenesshub @ gmail dot com
This article written by Simply Wall St is general. We Made a commentary based on historical data and analyst forecasts only using a neutral methodology and our articles are not intended to be financial advice. It does not make a recommendation to buy or sell any of your stock and does not take account of your objectives, or your financial situation regarding this article. We want to bring you long-term deep analysis driven by the fundamental data sector. Keep in mind that our analysis may not factor in the latest price-sensitive company declarations or qualitative material that helps out our community. Commonly Wall St has no authority in any stocks given above.
You can also read more articles on our Website